At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
09939 KINTOR PHARMA-B
Closed 05-08 15:59:37
2.920
+0.000
0.00%
High2.940
Low2.830
Vol1.56M
Open2.920
D1 Closing2.920
Amplitude3.77%
Mkt Cap1.46B
Tradable Cap1.46B
Total Shares499.00M
T/O4.49M
T/O Rate0.31%
Tradable Shares499.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Major A-Share Indices Open Lower; AI Applications, Pharmaceuticals, and Baijiu Lead Gains
ABBISKO-B (02256) Discloses Six Research Updates at 2026 AACR Meeting, Highlighting Innovations in Pan-KRAS, Fourth-Generation EGFR, and Synthetic Lethality
TRANSCENTA-B Reveals New Data Showing Potent Anti-Tumor Activity of Novel LIV1 ADC TST013 in Prostate Cancer and ER-Positive/HER2-Negative Breast Cancer PDX Models
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.